Apollo Funds Complete Acquisitions of Emerald and Questex, Creating a Scaled, B2B Experiential Events and Media Platform Positioned to Drive Sustained, Long- Term Growth

Announces Additional Executive Leadership Team Appointments

NEW YORK, July 14, 2026 – Apollo (NYSE: APO) today announced that Apollo-managed funds (the “Apollo Funds”) have completed the acquisitions of Emerald Holding, Inc. (NYSE: EEX) (“Emerald”) and Questex, LLC (“Questex”). The transaction brings together two highly complementary businesses to create a leading B2B experiential events and media platform with enhanced scale, expanded capabilities, and a strong foundation for growth.

As previously announced, Paul Miller has assumed the role of Chief Executive Officer of the combined company, and Hervé Sedky has transitioned to the role of senior advisor to the combined company. In addition, the combined company has made the following appointments to the executive leadership team:

  • Vince DiMaggio, named as Chief Financial Officer;
  • Issa Jouaneh, named as Chief Operating Officer;
  • Kate Spellman, named as Chief Commercial Officer;
  • Kurt Nelson, named as Chief Talent Officer; and
  • Sara Altschul, named as Chief Legal Officer and Company Secretary.

The two companies will be fully integrated over the coming months.

“This transaction combines two market leaders with iconic brands, deep customer relationships, and differentiated capabilities, to create a scaled platform positioned to accelerate organic growth, invest in innovation, and deliver even greater value for customers, employees and other stakeholders,” said Shahid Bosan, Managing Director at Apollo. “We look forward to supporting and working closely with the leadership team as they build a leading B2B events and media business.”

“Today marks an exciting milestone as we embark on a new chapter as one company,” said Mr. Miller. “By bringing together the best of Emerald and Questex, we are creating a stronger, differentiated platform with the scale, offerings, and talent to better serve our customers and partners. With Apollo’s support and a strong leadership team in place, we are well-positioned to execute against our strategy, expand our portfolio, and capitalize on the significant opportunities ahead.”

With the completion of the acquisition, Emerald’s common stock has ceased trading and will no longer be listed on the New York Stock Exchange. Emerald stockholders are receiving $5.03 per share in cash.

Advisors
Goldman Sachs & Co. LLC acted as the exclusive financial advisor and Fried, Frank, Harris, Shriver & Jacobson LLP acted as legal counsel to Emerald. Gibson, Dunn & Crutcher LLP acted as legal counsel to Questex. RBC Capital Markets and RAN Advisory acted as lead financial advisors and PJT Partners acted as financial advisor to the Apollo Funds. Akin Gump Strauss Hauer & Feld LLP acted as legal counsel to the Apollo Funds.

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of March 31, 2026, Apollo had approximately $1.03 trillion of assets under management. To learn more, please visit www.apollo.com.

About Emerald
Emerald Holding, Inc. is a leading U.S.-based B2B event organizer, empowering businesses year-round by expanding meaningful connections, developing influential content, and delivering powerful commerce-driven solutions. As the owner and operator of a curated portfolio of B2B events spanning trade shows, conferences, B2C showcases and a scaled Executive Peer Network platform. Emerald also delivers dynamic solutions across leading industries through its robust content and e-commerce marketplace. Emerald is a trusted partner for its thousands of customers, predominantly small and medium-sized businesses, playing a pivotal role in driving ongoing commerce through streamlined buying, selling, and networking opportunities. Powered by an experienced, talented and deeply engaged team, Emerald is fostering impactful engagement and delivering unparalleled market access with a commitment to driving business growth 365 days a year. For more: http://www.emeraldx.com.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking information may be identified by such terms as “believes”, “expects”, “will”, “may”, and other similar expressions. These statements are based on the current expectations as of the date hereof, and although they are believed to be reasonable, they are inherently uncertain and not guaranteed. These statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and other factors outside of Emerald’s control that may cause its business, industry, strategy, and financing activities to differ materially. See “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Emerald’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings for a discussion of factors that may affect Emerald’s business performance. Emerald undertakes no obligation to update or revise any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise

Contacts

For Emerald

Erica Bartsch
EVP, Strategy & Communications
Erica.Bartsch@Emeraldx.com

For Questex

Kate Spellman
Chief Commercial Officer
kspellman@questex.com

For Apollo

Noah Gunn
Global Head of Investor Relations
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
(212) 822-0491
Communications@apollo.com

The Hospitality Show Announces 2026 Speaker Lineup

MIAMI, July 13, 2026 (GLOBE NEWSWIRE) — The Hospitality Show today unveiled new speakers for its developing conference program, including Hilton President & CEO Chris Nassetta, Sandals Executive Chairman Adam Stewart, Accor Group Chief Strategy Officer Gilda Perez-Alvarado, Davidson Hospitality Group President & CEO Thom Geshay, and former Disney Head of Innovation and Creativity Duncan Wardle, along with more than a dozen additional industry executives.

The event, the hospitality industry’s premier conference dedicated to improving hotel operations and performance, takes place November 2-4 at the Miami Beach Convention Center in Miami Beach, Florida.

Produced by Questex and the American Hotel & Lodging Association (AHLA), The Hospitality Show is the industry’s only event dedicated to hotel operations, bringing together owners, operators, management companies, franchisees, investors, and leaders to discover strategies, technologies, and solutions that optimize time, operations, revenue, guest experience, and overall hotel performance.

Sessions at the 2026 conference will examine important issues hotel owners and operators are facing in today’s competitive tourism environment, from AI and labor to food and beverage strategy, commercial performance, guest expectations, and operational efficiency.

The developing speaker lineup includes executives from leading hotel brands, management companies, ownership groups, technology companies, education, and government, with more speakers to be announced.

  • Ritesh Agarwal, Founder and Group CEO, PRISM
  • Gilda Perez-Alvarado, Group Chief Strategy Officer, Accor
  • Nazpari Aydin, Co-Founder & CEO, Destination AI Forum
  • Malcolm Berg, Principal & Owner, EoA, Inc.
  • Thom Geshay, CEO & President, Davidson Hospitality Group
  • Esther Hertzfeld, Executive Editor, Hotel Management
  • Amy Hulbert, Vice President, Boutique and Upscale Brands, BWH Hotel Group
  • Alexi Khajavi, President, Hospitality & Real Estate, Questex
  • Carl Long, President & CEO, Purchasing Management International
  • Robyn Long, Director of Food & Beverage Solutions, Datassential
  • Rosanna Maietta, President & CEO, AHLA
  • Eliza McCoy, Vice President, Programs & Impact, AHLA Foundation
  • Chris Nassetta, President & CEO, Hilton
  • Brandy Rand, Vice President & Market Leader, Hospitality Group, Questex
  • Peter Ricci, Ed.D., Director, Hospitality & Tourism Management Program, Florida Atlantic University
  • Rich Russo, Principal, Highgate
  • Steve Sickel, CEO, IHG Owners Association
  • Adam Stewart, Executive Chairman, Sandals Resorts International
  • Duncan Wardle, Former Head of Innovation and Creativity, The Walt Disney Company

Featured sessions include an exclusive conversation with Hilton President & CEO Chris Nassetta, bold strategies for driving hotel growth from prominent hotel owners and operators, a close examination of what hotel owners want from brands and how brands can deliver, and innovative partnerships tied to major demand drivers like the World Cup.

For more information or to register, visit thehospitalityshow.com.

About The Hospitality Show
The Hospitality Show is an event for the entire hospitality ecosystem with one goal: operating hotels more efficiently. Produced by the American Hotel & Lodging Association (AHLA) and Questex, the event brings together top industry leaders, senior executives of hotel brands, owners, operators, management companies, procurement specialists, and their teams. The Hospitality Show 2026 takes place November 2-4, at the Miami Beach Convention Center in Miami, FL.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

About AHLA
The American Hotel & Lodging Association (AHLA) is the largest hotel association in America, representing more than 30,000 members from all segments of the industry nationwide – including iconic global brands, 80% of all franchised hotels, and the 16 largest hotel companies in the U.S. Headquartered in Washington, D.C., AHLA focuses on strategic advocacy, communications support, and workforce development programs to move the industry forward. Learn more at ahla.com

Media Contacts:  
Sarah Belizaire Greg Cohen
(646) 552-1118 (917) 714-8237
sarah.bb@bbcomms.global greg.cohen@bbcomms.global
   

The Hospitality Show Announces 2026 Speaker Lineup

MIAMI, July 13, 2026 (GLOBE NEWSWIRE) — The Hospitality Show today unveiled new speakers for its developing conference program, including Hilton President & CEO Chris Nassetta, Sandals Executive Chairman Adam Stewart, Accor Group Chief Strategy Officer Gilda Perez-Alvarado, Davidson Hospitality Group President & CEO Thom Geshay, and former Disney Head of Innovation and Creativity Duncan Wardle, along with more than a dozen additional industry executives.

The event, the hospitality industry’s premier conference dedicated to improving hotel operations and performance, takes place November 2-4 at the Miami Beach Convention Center in Miami Beach, Florida.

Produced by Questex and the American Hotel & Lodging Association (AHLA), The Hospitality Show is the industry’s only event dedicated to hotel operations, bringing together owners, operators, management companies, franchisees, investors, and leaders to discover strategies, technologies, and solutions that optimize time, operations, revenue, guest experience, and overall hotel performance.

Sessions at the 2026 conference will examine important issues hotel owners and operators are facing in today’s competitive tourism environment, from AI and labor to food and beverage strategy, commercial performance, guest expectations, and operational efficiency.

The developing speaker lineup includes executives from leading hotel brands, management companies, ownership groups, technology companies, education, and government, with more speakers to be announced.

  • Ritesh Agarwal, Founder and Group CEO, PRISM
  • Gilda Perez-Alvarado, Group Chief Strategy Officer, Accor
  • Nazpari Aydin, Co-Founder & CEO, Destination AI Forum
  • Malcolm Berg, Principal & Owner, EoA, Inc.
  • Thom Geshay, CEO & President, Davidson Hospitality Group
  • Esther Hertzfeld, Executive Editor, Hotel Management
  • Amy Hulbert, Vice President, Boutique and Upscale Brands, BWH Hotel Group
  • Alexi Khajavi, President, Hospitality & Real Estate, Questex
  • Carl Long, President & CEO, Purchasing Management International
  • Robyn Long, Director of Food & Beverage Solutions, Datassential
  • Rosanna Maietta, President & CEO, AHLA
  • Eliza McCoy, Vice President, Programs & Impact, AHLA Foundation
  • Chris Nassetta, President & CEO, Hilton
  • Brandy Rand, Vice President & Market Leader, Hospitality Group, Questex
  • Peter Ricci, Ed.D., Director, Hospitality & Tourism Management Program, Florida Atlantic University
  • Rich Russo, Principal, Highgate
  • Steve Sickel, CEO, IHG Owners Association
  • Adam Stewart, Executive Chairman, Sandals Resorts International
  • Duncan Wardle, Former Head of Innovation and Creativity, The Walt Disney Company

Featured sessions include an exclusive conversation with Hilton President & CEO Chris Nassetta, bold strategies for driving hotel growth from prominent hotel owners and operators, a close examination of what hotel owners want from brands and how brands can deliver, and innovative partnerships tied to major demand drivers like the World Cup.

For more information or to register, visit thehospitalityshow.com.

About The Hospitality Show
The Hospitality Show is an event for the entire hospitality ecosystem with one goal: operating hotels more efficiently. Produced by the American Hotel & Lodging Association (AHLA) and Questex, the event brings together top industry leaders, senior executives of hotel brands, owners, operators, management companies, procurement specialists, and their teams. The Hospitality Show 2026 takes place November 2-4, at the Miami Beach Convention Center in Miami, FL.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

About AHLA
The American Hotel & Lodging Association (AHLA) is the largest hotel association in America, representing more than 30,000 members from all segments of the industry nationwide – including iconic global brands, 80% of all franchised hotels, and the 16 largest hotel companies in the U.S. Headquartered in Washington, D.C., AHLA focuses on strategic advocacy, communications support, and workforce development programs to move the industry forward. Learn more at ahla.com

Media Contacts:
Sarah Belizaire Greg Cohen
(646) 552-1118 (917) 714-8237
sarah.bb@bbcomms.global greg.cohen@bbcomms.global

 

Registration Opens for Questex’s LDI 2026, Featuring Early Access to In-Depth LDInstitute™Training

Professionals across live events, entertainment technology, and production can now register for LDI 2026, for the first time, secure seats in sought-after LDInstitute™ courses nearly two months earlier than ever before

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Registration is now open for Live Design International (LDI) 2026, Questex’s must-attend annual event for global entertainment design and technology professionals. Taking place December 2-8, 2026, at the Las Vegas Convention Center, LDI will once again bring together the designers, programmers, engineers, technicians, production teams, manufacturers, and innovators shaping the future of live experiences.

This year’s event is already gearing up to be one of the most exciting in LDI’s history, with expanded professional development opportunities, hundreds of exhibitors, cutting-edge technology demonstrations, immersive experiences, and the industry’s most comprehensive education program.

Early Access to LDInstitute™—A First for LDI

For the first time, attendees can also register early for the highly anticipated LDInstitute™ professional training courses. Many Institute courses feature limited hands-on enrollment and routinely sell out, making early registration the best way to guarantee access to these sought-after training opportunities.

With more than 75 expert-led training courses, many featuring limited hands-on enrollment that sells out each year, early registration gives attendees the best opportunity to secure a seat in some of the industry’s most in-demand technical training.

“LDI is where the live events industry comes together to discover new technology, sharpen skills, and build the relationships that move careers—and our industry—forward,” said Marian Sandberg, Vice President and Brand Leader, LDI. “We’re excited to open registration for LDI 2026 and give attendees early access to our Institute courses. These small-group training experiences provide unparalleled hands-on learning and consistently fill quickly, so we encourage attendees to secure their seats early.”

Register for Industry-Leading LDInstitute™ Training

LDInstitute delivers intensive, hands-on education taught by respected industry professionals across lighting, networking, production technology, media servers, design, and live event systems.

Sessions include:

  • grandMA3 Beginner and grandMA3 Special Topics
  • ETC Eos and High End console Training
  • Setting Up, Testing, and Troubleshooting Lighting Control Systems and Networks
  • Vectorworks Training
  • Green Hippo and Pixera media server Training
  • Ethernet For Entertainment
  • Cutting-edge AI Training
  • Additional technical and professional development courses

The LDInnovation™ Conference Returns

The full LDInnovation™ Conference agenda and speaker lineup will be announced in August, featuring industry leaders, innovators, and practitioners exploring the trends, technologies, and creative ideas shaping the future of live events and entertainment production.

Register Early & Save: Super Early Bird Rates Through August 14

Attendees who register now can take advantage of Super Early Bird pricing through August 14, 2026, and secure the lowest available rates for LDI 2026 and reduced rates for LDInstitute Courses.

LDI 2026 will feature:

  • Hundreds of exhibitors showcasing the latest in lighting, audio, video, projection, staging, automation, rigging, and immersive technologies
  • The LDInnovation™ Conference
  • 75+ LDInstitute™ training courses
  • Live demonstrations
  • Networking events
  • Career development opportunities
  • Experiences celebrating the creativity and technology behind live entertainment

To register to attend LDI, click here. To view LDInstitute Courses, click here.

For sponsorship opportunities, contact Kelly Turner.

Follow LDI on Instagram, LinkedIn, Facebook, X, YouTube and TikTok.

About Live Design International (LDI)
Established in 1988, Live Design International (LDI) is built on a 36-year history as the essential trade show and conference for global live design professionals. Attendees come to LDI to see the latest gear and entertainment technology in action, covering audio, lighting, projection, video, staging, special effects, and XR. It is also a great opportunity to refresh knowledge and professional training, in addition to networking and finding inspiration from colleagues, manufacturers, and distributors at the vanguard of entertainment technology. For more information, visit http://www.ldishow.com/. LDI takes place December 2-8, 2026, in the West Hall of the Las Vegas Convention Center in Las Vegas, NV.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Charlene Soucy
LDI
csoucy@questex.com

Registration Opens for Questex’s LDI 2026, Featuring Early Access to In-Depth LDInstitute™Training

Professionals across live events, entertainment technology, and production can now register for LDI 2026, for the first time, secure seats in sought-after LDInstitute™ courses nearly two months earlier than ever before

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Registration is now open for Live Design International (LDI) 2026, Questex’s must-attend annual event for global entertainment design and technology professionals. Taking place December 2-8, 2026, at the Las Vegas Convention Center, LDI will once again bring together the designers, programmers, engineers, technicians, production teams, manufacturers, and innovators shaping the future of live experiences.

This year’s event is already gearing up to be one of the most exciting in LDI’s history, with expanded professional development opportunities, hundreds of exhibitors, cutting-edge technology demonstrations, immersive experiences, and the industry’s most comprehensive education program.

Early Access to LDInstitute™—A First for LDI

For the first time, attendees can also register early for the highly anticipated LDInstitute™ professional training courses. Many Institute courses feature limited hands-on enrollment and routinely sell out, making early registration the best way to guarantee access to these sought-after training opportunities.

With more than 75 expert-led training courses, many featuring limited hands-on enrollment that sells out each year, early registration gives attendees the best opportunity to secure a seat in some of the industry’s most in-demand technical training.

“LDI is where the live events industry comes together to discover new technology, sharpen skills, and build the relationships that move careers—and our industry—forward,” said Marian Sandberg, Vice President and Brand Leader, LDI. “We’re excited to open registration for LDI 2026 and give attendees early access to our Institute courses. These small-group training experiences provide unparalleled hands-on learning and consistently fill quickly, so we encourage attendees to secure their seats early.”

Register for Industry-Leading LDInstitute™ Training

LDInstitute delivers intensive, hands-on education taught by respected industry professionals across lighting, networking, production technology, media servers, design, and live event systems.

Sessions include:

  • grandMA3 Beginner and grandMA3 Special Topics
  • ETC Eos and High End console Training
  • Setting Up, Testing, and Troubleshooting Lighting Control Systems and Networks
  • Vectorworks Training
  • Green Hippo and Pixera media server Training
  • Ethernet For Entertainment
  • Cutting-edge AI Training
  • Additional technical and professional development courses

The LDInnovation™ Conference Returns

The full LDInnovation™ Conference agenda and speaker lineup will be announced in August, featuring industry leaders, innovators, and practitioners exploring the trends, technologies, and creative ideas shaping the future of live events and entertainment production.

Register Early & Save: Super Early Bird Rates Through August 14

Attendees who register now can take advantage of Super Early Bird pricing through August 14, 2026, and secure the lowest available rates for LDI 2026 and reduced rates for LDInstitute Courses.

LDI 2026 will feature:

  • Hundreds of exhibitors showcasing the latest in lighting, audio, video, projection, staging, automation, rigging, and immersive technologies
  • The LDInnovation™ Conference
  • 75+ LDInstitute™ training courses
  • Live demonstrations
  • Networking events
  • Career development opportunities
  • Experiences celebrating the creativity and technology behind live entertainment

To register to attend LDI, click here. To view LDInstitute Courses, click here.

For sponsorship opportunities, contact Kelly Turner.

Follow LDI on Instagram, LinkedIn, Facebook, X, YouTube and TikTok.

About Live Design International (LDI)
Established in 1988, Live Design International (LDI) is built on a 36-year history as the essential trade show and conference for global live design professionals. Attendees come to LDI to see the latest gear and entertainment technology in action, covering audio, lighting, projection, video, staging, special effects, and XR. It is also a great opportunity to refresh knowledge and professional training, in addition to networking and finding inspiration from colleagues, manufacturers, and distributors at the vanguard of entertainment technology. For more information, visit http://www.ldishow.com/. LDI takes place December 2-8, 2026, in the West Hall of the Las Vegas Convention Center in Las Vegas, NV.

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Charlene Soucy
LDI
csoucy@questex.com

Paul Miller to Lead Combined Emerald and Questex Business as Chief Executive Officer

Visionary Events and Media Operator to Drive Organic Growth and Unlock Full Value of New, Scaled, Leading B2B Events Platform

Emerald President and CEO Hervé Sedky to Serve as Senior Advisor Upon Close

 

NEW YORK, June 24, 2026 – The holding company formed to acquire Emerald Holding, Inc. (NYSE: EEX) (“Emerald”) and Questex, LLC (“Questex”) in connection with the previously announced acquisitions by Apollo-managed funds (the “Apollo Funds”) today announced that Paul Miller, current Chief Executive Officer of Questex, will lead the combined company as CEO, effective upon closing of the transaction.

Following the close of the transaction, Hervé Sedky will transition from his current role as President and Chief Executive Officer of Emerald to serve as a senior advisor to the combined company.

Mr. Miller brings over three decades of experience across the events, information services, and media industries and a track record of increasing revenue streams, scaling multi-vertical platforms, and driving growth across cycles. Since becoming CEO of Questex in 2018, he has transformed and expanded the company’s portfolio across industries, including hospitality, travel, healthcare, life sciences, beauty, and technology, achieving remarkable growth in revenue and profit. With deep operational expertise and experience, including successfully integrating acquisitions and expanding innovative customer engagement capabilities powered by first-party data, Mr. Miller is well positioned to bring Emerald and Questex together to drive continued organic growth, pursue strategic acquisitions and realize the full value of the combined business.

“Paul is an experienced operator who shares our vision for building a scaled, customer-centric platform at the forefront of the B2B events industry,” said Shahid Bosan, Managing Director at Apollo. “We are confident in his ability to unite these two organizations to create a distinct platform that is well-positioned for sustained growth and long-term value creation.”

“I am honored to have the opportunity to lead the combined company and work alongside such a talented group of employees across both Emerald and Questex,” said Mr. Miller. “As we embark on this next chapter, my focus will be on bringing together the strengths of both organizations to create a scaled, highly complementary platform that is uniquely positioned to capture the growing demand for trusted, in-person gatherings, leveraging the strength of both companies’ customer relationships and engagement capabilities to continue to deliver value for all our respective stakeholders.”

“Leading Emerald and building a portfolio of market-leading brands alongside an extraordinary team has been one of the defining privileges of my career,” said Mr. Sedky. “This combination creates a stronger platform – one defined by greater scale, deep expertise, expanded capabilities, and a shared commitment to delivering meaningful value for our customers, exhibitors, and partners. I look forward to working with Paul and the rest of the leadership team as we build on that foundation and guide both companies into this next chapter.”

 

Transaction Update
The previously announced transaction is still expected to be completed in the second half of 2026, subject to customary closing conditions and regulatory approvals.

 

About Paul Miller
Paul Miller currently serves as CEO of Questex, where he has shaped the company’s growth strategy and advanced its position as a next-generation information services company across core markets with events at the center and year-round engagement driving deep data to produce better outcomes for customers. Prior to joining Questex in 2018, Mr. Miller served as President of Informa’s Industry & Infrastructure Intelligence where he brought a high level of innovation and creativity to help customers achieve superior ROI on marketing investments. Earlier in his career, he served as President of Penton’s Industry Group and held a variety of leadership positions at UBM, including CEO of UBM Tech, where he led the business’s event expansion into international markets as well as growing digital content and services. Mr. Miller is a Fellow of the Chartered Institute of Marketing.

 

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of March 31, 2026, Apollo had approximately $1.03 trillion of assets under management. To learn more, please visit www.apollo.com.

 

About Emerald
Emerald Holding, Inc. is a leading U.S.-based B2B event organizer, empowering businesses year-round by expanding meaningful connections, developing influential content, and delivering powerful commerce-driven solutions. As the owner and operator of a curated portfolio of B2B events spanning trade shows, conferences, B2C showcases and a scaled Executive Peer Network platform. Emerald also delivers dynamic solutions across leading industries through its robust content and e-commerce marketplace. Emerald is a trusted partner for its thousands of customers, predominantly small and medium-sized businesses, playing a pivotal role in driving ongoing commerce through streamlined buying, selling, and networking opportunities. Powered by an experienced, talented and deeply engaged team, Emerald is fostering impactful engagement and delivering unparalleled market access with a commitment to driving business growth 365 days a year. For more: https://www.emeraldx.com.

 

About Questex
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

 

Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking information may be identified by such terms as “believes”, “expects”, “will”, “may”, and other similar expressions. In particular, the forward-looking information contained in this press release includes statements regarding the proposed transaction described herein, including the proposed timing and steps contemplated in respect of the proposed transaction and approvals with respect thereto. These statements are based on the current expectations as of the date hereof, and although they are believed to be reasonable, they are inherently uncertain and not guaranteed. These statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and other factors outside of Emerald’s control that may cause its business, industry, strategy, financing activities and the ability of the parties to complete the proposed transaction to differ materially. See “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Emerald’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings for a discussion of factors that may affect Emerald’s business performance. Emerald undertakes no obligation to update or revise any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise.

 

Contacts

Noah Gunn
Global Head of Investor Relations
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
(212) 822-0491
Communications@apollo.com

Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

Conference set to take place October 29-30 in Boston

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) — Questex’s Fierce Life Sciences today announces the agenda for the PODD: Partnership Opportunities in Drug Delivery Conference, the premier gathering for drug delivery industry leaders. Set to take place October 29-30, 2026, at the Sheraton Boston Hotel, the 16th annual PODD conference brings together over 1,000 executives, innovators and strategic decision-makers to advance the design and development of drug delivery systems and devices to improve patient lives.

“As someone working at the forefront of emerging modalities, I see PODD as uniquely valuable because it brings together the full ecosystem needed to translate novel biology into viable therapies, where delivery often becomes the gating factor,” said Suman Luthra, Director, Discovery Pharmaceutical Sciences, Merck.

With more than 150 sessions across multiple tracks, the PODD conference features keynotes, panels, roundtables and case studies with thought leaders from across the pharma and drug delivery ecosystem.

2026 featured sessions include:

  • Keynote: Dr George Yancopoulos, Regeneron’s Co-Founder, Board Co-Chair, President and Chief Scientific Officer will join MIT’s Dr Robert Langer, a pioneer in the research and development of drug delivery technology, to discuss the state of innovation in the drug delivery industry.
  • Patient Keynote: Sabrena Gates will share her family’s journey with Luxturna, a gene therapy designed to treat inherited retinal diseases caused by mutations in both copies of the RPE65 gene.
  • How Companies Use AI to Support Drug Delivery will be addressed by AstraZeneca’s Head of Advanced Drug Delivery, Dr Annette Bak, Intrepid Lab’s Co-Founder & CEO, Dr Christine Allen, GSK’s VP, Portfolio and Technology Development, Dr Manish Gupta, Eli Lilly and Company’s VP, Drug Delivery, Device, Connected Solutions & Innovation, Dr Anand Subramony, and Bristol Myers Squibb’s Director, Portfolio Strategy & Integration, Rashmi Thakur.
  • Johnson & Johnson’s Scientific Director, Oral Peptide Formulation Technologies, Wouter Müllers, Vertex Pharmaceutical’s VP, Combination Devices, David Dunleavy, Daiichi Sankyo’s VP, Global Search & Evaluation – Early Stage, Global Business Development, Dr Shiv Krishnan, and Astellas Pharma’s, Senior Director, Head of DDS, Dr Takayuki Yoshida will present on their companies’ partnering philosophy, current needs and scouting interests, as related to drug delivery and enabling technologies as part of the Pharma Company Spotlights.
  • The Successful Partnering between Pharma, Drug Delivery and Academia panel is led by Boehringer Ingelheim’s Senior Associate Director, Innovation Technology, Dr Jill Steinbach-Rankins, with Johnson & Johnson Innovative Medicines’ Senior Director External Innovation DPDS, Dr Elena Diez Cecilia, MIT’s Director, Strategic Alliances & Partnerships, Dr Tarek Fadel, and CSL Bering’s Search & Evaluation, Immunoglobulin (Ig) Therapeutic Area and Technologies Lead Dr Sarah Tao.
  • Sun Pharmaceutical’s Mark Simon, UnitedHealth Group’s, Lambert van der and Sherman Healthcare Solutions’ Dr Michael Sherman lead the Payer discussion on how companies can position their drug delivery-enabled therapies for reimbursement, the impact of direct-to-consumer accessibility on GLP-1 drugs, and cell and gene therapies for non-malignancies and conditions for which there are already effective treatments.

The PODD conference will also feature multi-stakeholder participation, including leaders from AbbVie, Alexion, Alnylam Pharmaceuticals, Astellas Pharma, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi USA, CSL Bering, Daiichi Sankyo, Eli Lilly & Company, Genentech, Gilead Sciences, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Sun Pharma, Takeda Pharmaceuticals, Teva Pharmaceuticals, Upstream Bio, Vertex Pharmaceuticals and more.

The 2026 Drug Delivery Technology Presentations cover:

  • Injectable Formulations & Technologies
  • Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
  • Novel Injectable & Non-Injectable Technologies
  • Novel Devices, Self-Injectables, Wearables & Connected Devices
  • Novel Device Technologies
  • Cell, Gene, & Novel Biologics Delivery
  • Novel Materials & Excipient Innovation
  • Self-Injection Devices, Syringes, Primary Container & Packaging Solutions

To register to attend PODD, click here.

Learn more about sponsorship opportunities, here.

About PODD: Partnership Opportunities in Drug Delivery Conference

Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals, and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.

To learn more about the PODD conference, please visit PODDConference.com.

About Fierce Life Sciences

Fierce Life Sciences Events offers a full suite of news, analysis and event education, all in one place. From preclinical research to market and beyond, our team of editors and handpicked experts deliver insights you can source with confidence and events, both virtual and live, that support professional and business growth.

About Questex

Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact

Allyson Adams

PODD

aadams@questex.com 

Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda

Conference set to take place October 29-30 in Boston

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) — Questex’s Fierce Life Sciences today announces the agenda for the PODD: Partnership Opportunities in Drug Delivery Conference, the premier gathering for drug delivery industry leaders. Set to take place October 29-30, 2026, at the Sheraton Boston Hotel, the 16th annual PODD conference brings together over 1,000 executives, innovators and strategic decision-makers to advance the design and development of drug delivery systems and devices to improve patient lives.

“As someone working at the forefront of emerging modalities, I see PODD as uniquely valuable because it brings together the full ecosystem needed to translate novel biology into viable therapies, where delivery often becomes the gating factor,” said Suman Luthra, Director, Discovery Pharmaceutical Sciences, Merck.

With more than 150 sessions across multiple tracks, the PODD conference features keynotes, panels, roundtables and case studies with thought leaders from across the pharma and drug delivery ecosystem.

2026 featured sessions include:

  • Keynote: Dr George Yancopoulos, Regeneron’s Co-Founder, Board Co-Chair, President and Chief Scientific Officer will join MIT’s Dr Robert Langer, a pioneer in the research and development of drug delivery technology, to discuss the state of innovation in the drug delivery industry.
  • Patient Keynote: Sabrena Gates will share her family’s journey with Luxturna, a gene therapy designed to treat inherited retinal diseases caused by mutations in both copies of the RPE65 gene.
  • How Companies Use AI to Support Drug Delivery will be addressed by AstraZeneca’s Head of Advanced Drug Delivery, Dr Annette Bak, Intrepid Lab’s Co-Founder & CEO, Dr Christine Allen, GSK’s VP, Portfolio and Technology Development, Dr Manish Gupta, Eli Lilly and Company’s VP, Drug Delivery, Device, Connected Solutions & Innovation, Dr Anand Subramony, and Bristol Myers Squibb’s Director, Portfolio Strategy & Integration, Rashmi Thakur.
  • Johnson & Johnson’s Scientific Director, Oral Peptide Formulation Technologies, Wouter Müllers, Vertex Pharmaceutical’s VP, Combination Devices, David Dunleavy, Daiichi Sankyo’s VP, Global Search & Evaluation – Early Stage, Global Business Development, Dr Shiv Krishnan, and Astellas Pharma’s, Senior Director, Head of DDS, Dr Takayuki Yoshida will present on their companies’ partnering philosophy, current needs and scouting interests, as related to drug delivery and enabling technologies as part of the Pharma Company Spotlights.
  • The Successful Partnering between Pharma, Drug Delivery and Academia panel is led by Boehringer Ingelheim’s Senior Associate Director, Innovation Technology, Dr Jill Steinbach-Rankins, with Johnson & Johnson Innovative Medicines’ Senior Director External Innovation DPDS, Dr Elena Diez Cecilia, MIT’s Director, Strategic Alliances & Partnerships, Dr Tarek Fadel, and CSL Bering’s Search & Evaluation, Immunoglobulin (Ig) Therapeutic Area and Technologies Lead Dr Sarah Tao.
  • Sun Pharmaceutical’s Mark Simon, UnitedHealth Group’s, Lambert van der and Sherman Healthcare Solutions’ Dr Michael Sherman lead the Payer discussion on how companies can position their drug delivery-enabled therapies for reimbursement, the impact of direct-to-consumer accessibility on GLP-1 drugs, and cell and gene therapies for non-malignancies and conditions for which there are already effective treatments.

The PODD conference will also feature multi-stakeholder participation, including leaders from AbbVie, Alexion, Alnylam Pharmaceuticals, Astellas Pharma, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi USA, CSL Bering, Daiichi Sankyo, Eli Lilly & Company, Genentech, Gilead Sciences, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, Sun Pharma, Takeda Pharmaceuticals, Teva Pharmaceuticals, Upstream Bio, Vertex Pharmaceuticals and more.

The 2026 Drug Delivery Technology Presentations cover:

  • Injectable Formulations & Technologies
  • Oral, Nasal, Pulmonary & Other Non-Injectable Technologies
  • Novel Injectable & Non-Injectable Technologies
  • Novel Devices, Self-Injectables, Wearables & Connected Devices
  • Novel Device Technologies
  • Cell, Gene, & Novel Biologics Delivery
  • Novel Materials & Excipient Innovation
  • Self-Injection Devices, Syringes, Primary Container & Packaging Solutions

To register to attend PODD, click here.

Learn more about sponsorship opportunities, here.

About PODD: Partnership Opportunities in Drug Delivery Conference

Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals, and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations.

To learn more about the PODD conference, please visit PODDConference.com.

About Fierce Life Sciences

Fierce Life Sciences Events offers a full suite of news, analysis and event education, all in one place. From preclinical research to market and beyond, our team of editors and handpicked experts deliver insights you can source with confidence and events, both virtual and live, that support professional and business growth.

About Questex

Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact

Allyson Adams

PODD

aadams@questex.com 

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) — DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is now part of Questex’s Fierce Life Sciences, takes place September 15-16, 2026, at the Sheraton Boston Hotel.

The first line up of senior level clinical operation executives include:

  • Jennifer Sheller, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck
  • David Carruthers, VP, Head of Global Clinical Operations, BioPharmaceuticals R&D, AstraZeneca
  • Nikki Amaratunge, VP, Clinical Development Operations, Head of Clinical Site Management, AbbVie
  • Karen Correa, VP, Clinical Development Operations, Boehringer Ingelheim
  • Bari Kowal, SVP, Head Development Operations & Portfolio Management, Regeneron

The 2026 Keynotes include:

John Volanthen, world-renowned British cave diver who was integral in the rescue of the Thai Boys’ soccer team in 2018 gives the disruptive keynote.

Gunnar Esiason, Cystic Fibrosis Patient Advocate and industry executive shares his three-decade patient journey.

Janelle A. Sabo, SVP of Clinical Research Capabilities, Eli Lilly and Company, presents the Industry Keynote on the most innovative trends shaping the future of clinical research.

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, speaks on change management, why innovation adoption stalls and how to overcome it.

Jeremy Walsh, Former Chief AI Officer, US Food and Drug Administration, speaks on real-time clinical trials.

Core themes of the agenda include real-time clinical trials, scalable innovation, workforce development, enterprise-wide AI adoption, and the redesign of clinical operating models to support faster, more efficient development.

Other presenting pharmaceutical companies include Abeona Therapeutics, Acelot Inc., Alexion, Alnylam Pharmaceuticals, Amgen, AskBio, Astellas, AstraZeneca, Bayer, BeOne Medicines, Biogen, BMS, CSL, Daiichi Sankyo, Eli Lilly, Genmab, Gilead Sciences, GSK, J&J Innovative Medicine, Jazz Pharmaceuticals, Kyowa Kirin, Novartis, Novo Nordisk, Parabilis Medicines, Pfizer, Sanofi, Takeda, Teva Pharmaceuticals, and Vertex Pharmaceuticals.

“DPHARM 2026 will showcase the latest innovative approaches and practical strategies to scale what works, from AI to operating models, to drive measurable improvements in trial performance and patient experience.” said Tracey Kimball, DPHARM Conference Director.

In addition to the keynotes, DPHARM 2026 has over 200 speakers. The DPHARM agenda is carefully curated with the guidance of more than 70 advisors representing pharmaceutical senior clinical operation executives, patient advocacy, clinical sites, innovative tech and service companies, academia and regulatory authorities.

DPHARM will be preceded by the Partnerships with Sites Summit, September 14, 2026. To learn more, visit www.partnershipswithsites.com/

For the full DPHARM agenda, visit www.DPHARMconference.com.

About DPHARM:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders report on innovations that are modernizing clinical trials and reducing patient burden. The concept of DPHARM was founded by Pfizer and Johnson & Johnson, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM takes place September 15-16 at the Sheraton Boston Hotel in Boston, MA.

About Questex:
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Allyson Adams
DPHARM
aadams@questex.com         

Questex’s DPHARM Announces Senior Leadership and Keynotes for the 16th Annual Conference

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) — DPHARM, the leading innovation event for clinical trial operation executives, announces the 16th annual conference agenda including its senior leadership and keynotes. DPHARM which is now part of Questex’s Fierce Life Sciences, takes place September 15-16, 2026, at the Sheraton Boston Hotel.

The first line up of senior level clinical operation executives include:

  • Jennifer Sheller, SVP, Head of Global Clinical Trial Operations, Global Clinical Development, Merck
  • David Carruthers, VP, Head of Global Clinical Operations, BioPharmaceuticals R&D, AstraZeneca
  • Nikki Amaratunge, VP, Clinical Development Operations, Head of Clinical Site Management, AbbVie
  • Karen Correa, VP, Clinical Development Operations, Boehringer Ingelheim
  • Bari Kowal, SVP, Head Development Operations & Portfolio Management, Regeneron

The 2026 Keynotes include:

John Volanthen, world-renowned British cave diver who was integral in the rescue of the Thai Boys’ soccer team in 2018 gives the disruptive keynote.

Gunnar Esiason, Cystic Fibrosis Patient Advocate and industry executive shares his three-decade patient journey.

Janelle A. Sabo, SVP of Clinical Research Capabilities, Eli Lilly and Company, presents the Industry Keynote on the most innovative trends shaping the future of clinical research.

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine, speaks on change management, why innovation adoption stalls and how to overcome it.

Jeremy Walsh, Former Chief AI Officer, US Food and Drug Administration, speaks on real-time clinical trials.

Core themes of the agenda include real-time clinical trials, scalable innovation, workforce development, enterprise-wide AI adoption, and the redesign of clinical operating models to support faster, more efficient development.

Other presenting pharmaceutical companies include Abeona Therapeutics, Acelot Inc., Alexion, Alnylam Pharmaceuticals, Amgen, AskBio, Astellas, AstraZeneca, Bayer, BeOne Medicines, Biogen, BMS, CSL, Daiichi Sankyo, Eli Lilly, Genmab, Gilead Sciences, GSK, J&J Innovative Medicine, Jazz Pharmaceuticals, Kyowa Kirin, Novartis, Novo Nordisk, Parabilis Medicines, Pfizer, Sanofi, Takeda, Teva Pharmaceuticals, and Vertex Pharmaceuticals.

“DPHARM 2026 will showcase the latest innovative approaches and practical strategies to scale what works, from AI to operating models, to drive measurable improvements in trial performance and patient experience.” said Tracey Kimball, DPHARM Conference Director.

In addition to the keynotes, DPHARM 2026 has over 200 speakers. The DPHARM agenda is carefully curated with the guidance of more than 70 advisors representing pharmaceutical senior clinical operation executives, patient advocacy, clinical sites, innovative tech and service companies, academia and regulatory authorities.

DPHARM will be preceded by the Partnerships with Sites Summit, September 14, 2026. To learn more, visit www.partnershipswithsites.com/

For the full DPHARM agenda, visit www.DPHARMconference.com.

About DPHARM:
DPHARM®: Disruptive Innovations to Modernize Clinical Research offers an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders report on innovations that are modernizing clinical trials and reducing patient burden. The concept of DPHARM was founded by Pfizer and Johnson & Johnson, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM takes place September 15-16 at the Sheraton Boston Hotel in Boston, MA.

About Questex:
Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact
Allyson Adams
DPHARM
aadams@questex.com